Foundational Discovery Selective Senolytic Elimination in Aged Mice (Cell, 2017 Baar et al.) FOXO4-DRI Restores Fitness, Fur Density, Renal and Liver Function in Aged Mice The foundational study introducing FOXO4-DRI as a senolytic peptide was published in Cell by Baar and colleagues in 2017
It helps us heal after injury, fight infection, and recover from physical stress
Using angiogenesis-promoting agents in patients with undiagnosed malignancies could theoretically accelerate disease progression
found that injecting DBV (0.1 mg/kg) at ST36 of the right hind leg for 2 weeks and then administering oxaliplatin (10 mg/kg) resulted in significantly decreased ipsilateral mechanical allodynia (Yoon et al., 2013)
"Vitamin B 12 Deficiency Disorders of Nutrition"
To reduce risks: Only buy from trusted vendors with third-party testing Avoid products that dont publish full peptide identity and certificate of analysis (CoA) Be cautious of capsule or supplement brands claiming clinical-grade results Side Effects and Tolerability BPC157 is generally considered well-tolerated, especially in injectable form
